Inventor · disambiguated record
Lawrence Fang
Also filed as: FANG LAWRENCE · FANG LAWRENCE Y
26 granted patents·11 pending applications·284 citations·filing 1983–2006
96Inventor score
Top patents by PatentIndex Score
37 records- 0194US7176242B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesUPJOHN CO·Filed 2002·Granted Feb 13, 2007·92 cites·20 claims
- 0290US7034182B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted Apr 25, 2006·37 cites·45 claims
- 0384US6992081B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted Jan 31, 2006·13 cites·8 claims
- 0484US6737420B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted May 18, 2004·14 cites·13 claims
- 0584US5484940ASubstituted 3-indolyl-5-pyrazolone compoundsFiled 1994·Granted Jan 16, 1996·27 cites·11 claims
- 0684US5129939APollen suppressant comprising a 5-oxy- or amino-substituted cinnolineORSAN·Filed 1990·Granted Jul 14, 1992·3 cites·11 claims
- 0783US7030239B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2004·Granted Apr 18, 2006·13 cites·5 claims
- 0882US7276484B2Dipeptide inhibitors of β-secretaseELAN PHARM INC·Filed 2005·Granted Oct 2, 2007·4 cites·5 claims
- 0982US7214715B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted May 8, 2007·18 cites·100 claims
- 1079US4756740APollen suppressant comprising a fused pyridazineLAFARGE COPPEE·Filed 1986·Granted Jul 12, 1988·2 cites·16 claims
- 1177US4729782APollen suppressant comprising a fused pyridazinoneLAFARGE COPPEE·Filed 1985·Granted Mar 8, 1988·13 cites·41 claims
- 1276US6864240B1Dipeptide inhibitors of β-secretaseELAN PHARM INC·Filed 2000·Granted Mar 8, 2005·3 cites·37 claims
- 1376US5183891AMethod for the preparation of substituted 1,4-dihydro-4-oxo-cinnoline-3-carboxylic acid, esters and salts thereof, and intermediates used in their preparationORSAN·Filed 1989·Granted Feb 2, 1993·12 cites·19 claims
- 1469US7169759B1Tetrapeptide inhibitors of β-secretaseELAN PHARM INC·Filed 2000·Granted Jan 30, 2007·1 cites·111 claims
- 1568US7119085B2Methods to treat alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted Oct 10, 2006·2 cites·10 claims
- 1663US4604134APollen suppressant comprising a fused pyridazineLAFARGE COPPEE·Filed 1983·Granted Aug 5, 1986·5 cites·13 claims
- 1761US6117901AN-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for useATHENA NEUROSCIENCES INC·Filed 1997·Granted Sep 12, 2000·18 cites·23 claims
- 1861US2008058336A1Methods to Treat Alzheimer's DiseaseELAN PHARM INC·Filed 2006·Application pending·0 cites
- 1960US2006276642A1Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2006·Application pending·0 cites
- 2058US6767918B2N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2002·Granted Jul 27, 2004·0 cites·29 claims
- 2156US6642261B2N-(aryl/heteroarylacety) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Nov 4, 2003·0 cites·17 claims
- 2256US2006287306A1Compounds to treat alzheimer's diseaseELAN PHARM INC·Filed 2006·Application pending·0 cites
- 2353US7432389B2Compounds for the treatment of Alzheimer's diseaseELAN PHARM INC·Filed 2006·Granted Oct 7, 2008·0 cites·5 claims
- 2453US4561881APollen suppressant comprising a pyridazolylamineLAFARGE COPPEE·Filed 1983·Granted Dec 31, 1985·3 cites·37 claims
- 2551US2009074746A1Compounds to treat alzheimer's diseaseALZHEIMER S COLLABORATION·Filed 2004·Application pending·0 cites
- 2648US2006079533A1Methods of treating alzheimer's diseaseNIEMAN JAMES A·Filed 2002·Application pending·0 cites
- 2748US2007213407A1Compounds to treat Alzheimer's diseaseELAN PHARMACEUTICALS AND PHARM·Filed 2006·Application pending·0 cites
- 2846US2003096864A1Compounds to treat alzheimer's diseaseFiled 2001·Application pending·0 cites
- 2943US2006074098A1Methods of treatment of amyloidosis using ethanolcyclicamine aspartyl protease inhibitorsHOM ROY·Filed 2005·Application pending·0 cites
- 3043US2008166332A1Methods of Treatment of Amyloidosis Using Subsituted Ethanolcyclicamine Aspartyl Protease InhibitorsELAN PHARM INC·Filed 2005·Application pending·0 cites
- 3139US5304672AMethod for the preparation of substituted 1,4-dihydro-4-oxo-cinnoline-3-carboxylic acid, esters and salts thereof, and intermediates used in their preparationORSAN·Filed 1992·Granted Apr 19, 1994·1 cites·6 claims
- 3235US2005239832A1Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 3335US2006014790A1Methods of treatment of amyloidosis using spirocyclohexane aspartyl-protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 3434US6333351B1N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1999·Granted Dec 25, 2001·1 cites·20 claims
- 3534US5332716APollen suppressant comprising a 5-oxy- or amino-substituted cinnolineLABOVITZ JEFFREY·Filed 1988·Granted Jul 26, 1994·1 cites·10 claims
- 3632US6313152B1N(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1999·Granted Nov 6, 2001·0 cites·12 claims
- 3732US5696055APollen suppressant comprising a 5-oxy- or amino substituted cinnolineHYBRINOVA S A·Filed 1992·Granted Dec 9, 1997·1 cites·41 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →